Consult a doctor to get help with weight loss
Wegovy is a weight loss medication that can help with long-term weight management. As a glucagon-like peptide-1 (GLP-1) medication,
Wegovy is appropriate for adults battling one or more conditions besides their weight, such as dyslipidemia, type 2 diabetes, hypertension, or another disease comorbid with being overweight or obese.
Dr. Chrysoula I. Liakou MD, PhD
43
Wegovy is an approved weight loss medication for overweight and obese adults with various comorbidities. Novo Nordisk produces the drug and has been on the market since 2011.
Suppose your body mass index (BMI) is over 27, and you suffer from high blood pressure, type 2 diabetes, high cholesterol, or other diseases afflicting adults above a healthy weight. In that case, Wegovy could be right for you.
Wegovy is a GLP-1 class drug that reduces feelings of hunger and increases feelings of satiety among individuals above a normal BMI.
You cannot buy Wegovy directly through this platform. However, you can consult a licensed doctor online who will assess your situation and determine whether treatment is appropriate. If suitable, the doctor may guide you on the next steps for obtaining a prescription.
Wegovy may be suitable for adults with a body mass index (BMI) of 30 or higher, or 27 and above with related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol. A doctor will evaluate your medical history before recommending treatment.
Wegovy contains semaglutide, a GLP-1 medication that helps reduce appetite and increase feelings of fullness. This can lead to reduced calorie intake and support long-term weight management when combined with lifestyle changes.
Yes. A consultation is required to ensure the treatment is safe and appropriate for you. Depending on your symptoms and medical history, this may involve an online assessment or a video consultation with a doctor.
Wegovy works gradually. Some patients notice reduced appetite within the first few weeks, but meaningful weight loss typically occurs over several months when combined with diet and lifestyle changes.
Clinical studies have shown that patients using Wegovy alongside lifestyle changes can lose around 10–15% of their body weight over time. Results vary depending on individual factors and adherence.
Wegovy is not suitable for people with a history of medullary thyroid cancer, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or certain pancreatic conditions. It is also not recommended for those with known hypersensitivity to semaglutide.
Common side effects may include nausea, vomiting, diarrhoea, constipation, and reduced appetite. These are usually mild and improve over time, but a doctor should always assess suitability before starting treatment.
Wegovy may be effective in weight loss, and users can experience weight loss when the medication is combined with lifestyle changes.
In studies of Wegovy users, those who adopted reduced-calorie diets and increased physical activity lost 15% of their starting body weight.